New Obesity Drug Leads to 85-Pound Weight Loss in Clinical Trial
The landscape of obesity treatment is undergoing a seismic shift. For decades, the medical community relied on lifestyle interventions—diet and exercise—with limited pharmacological support. Today, we are entering the era of “triple-hormone” therapy, led by experimental breakthroughs from pharmaceutical giants like Eli Lilly. The Rise of Triple-Action Weight Loss Medications While current market leaders like … Read more